Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Ispaghula husk (Laxative)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ispaghula husk 3.5g efferv gran sach gluten free sugar free
0106010E0AAADAD
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | 108,047 |
|
Ispaghula husk 3.5g gran for susp sachets gluten free
0106010E0AAATAT
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | 2,864 |
|
Ispaghula husk 3.5g gran for susp sach GF SF
0106010E0AAAUAU
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | 627 |
|
Generic Solgar Psyllium husks fibre 500mg capsules
0106010E0AAAWAW
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Ispaghula husk 3.4g oral pdr sachets gluten free sugar free
0106010E0AAAJAJ
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Ispaghula husk 3.5g oral pdr sachets gluten free sugar free
0106010E0AAASAS
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Ispaghula husk 6g oral powder sachets gluten free sugar free
0106010E0AAAKAK
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Ispaghula husk 90% granules for oral suspension sugar free
0106010E0AAACAC
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Ispaghula husk oral powder sugar free
0106010E0AAAVAV
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.